WOOF · Petco Health & Wellness Company, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $1.46B | $1.49B | $1.49B | $1.51B | $1.52B | $1.53B | $1.49B | $1.53B | $1.56B |
| Cost of Revenue | - | $895.40M | $903.21M | $923.43M | $935.68M | $943.03M | $950.48M | $944.16M | $937.73M | $951.43M |
| Gross Profit | - | $569.01M | $585.32M | $569.97M | $575.76M | $580.73M | $578.66M | $550.00M | $593.00M | $604.48M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | $539.82M | $542.30M | $553.61M | $571.78M | $578.26M | $595.44M | $559.61M | $568.97M | $576.87M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | $49.37M | - | - | $49.59M | - | - | $49.26M |
| Operating Income | - | $29.20M | $43.02M | $16.36M | $3.98M | $2.47M | ($16.78M) | ($1.23B) | $24.04M | $27.62M |
| Interest Expense | - | $32.83M | $33.30M | $33.49M | $35.80M | $36.80M | $36.82M | $36.56M | $37.49M | $37.20M |
| Income Tax | - | ($6.28M) | $746.0K | $495.0K | ($857.0K) | ($4.65M) | ($4.48M) | ($22.90M) | $6.73M | ($1.01M) |
| Net Income | - | $9.33M | $13.97M | ($11.66M) | ($16.67M) | ($24.82M) | ($46.48M) | ($1.24B) | ($14.61M) | ($1.89M) |
| EPS - Basic | - | $0.03 | $0.05 | ($0.04) | ($0.06) | ($0.09) | ($0.17) | ($4.63) | ($0.05) | ($0.01) |
| EPS - Diluted | - | $0.03 | $0.05 | ($0.04) | ($0.06) | ($0.09) | ($0.17) | ($4.63) | ($0.05) | ($0.01) |
Balance Sheet
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $256.74M | $237.41M | $188.75M | $133.34M | $116.67M | $127.62M | $89.72M | $139.78M | $173.01M | $148.94M |
| Accounts Receivable | $45.81M | $42.90M | $34.52M | $36.08M | $40.43M | $47.03M | $42.08M | $50.18M | $66.26M | $45.41M |
| Inventory | $590.21M | $617.90M | $608.51M | $645.47M | $690.29M | $672.33M | $681.02M | $730.15M | $675.44M | $667.94M |
| Accounts Payable | $450.55M | $429.98M | $423.27M | $473.91M | $447.67M | $474.50M | $464.52M | $486.63M | $477.75M | $393.80M |
| Current Assets | $1.02B | $1.01B | $939.56M | $920.43M | $931.78M | $941.89M | $904.05M | $1.01B | $1.02B | $976.81M |
| Total Assets | $5.17B | $5.21B | $5.15B | $5.12B | $5.21B | $5.28B | $5.26B | $5.43B | $6.66B | $6.57B |
| Current Liabilities | $1.13B | $1.10B | $1.06B | $1.08B | $1.11B | $1.12B | $1.07B | $1.11B | $1.07B | $996.89M |
| Long-term Debt | $1.49B | $1.58B | $1.58B | $1.58B | $1.58B | $1.58B | $1.57B | $1.57B | $1.59B | $1.61B |
| Total Liabilities | $4.01B | $4.05B | $4.01B | $4.01B | $4.09B | $4.15B | $4.10B | $4.23B | $4.25B | $4.17B |
| Stockholders' Equity | $1.16B | $1.16B | $1.14B | $1.11B | $1.12B | $1.13B | $1.16B | $1.19B | $2.41B | $2.40B |
| Retained Earnings | ($1.14B) | ($1.14B) | ($1.15B) | ($1.16B) | ($1.14B) | ($1.12B) | ($1.09B) | ($1.02B) | $216.47M | $231.07M |
Cash Flow
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | ($15.45M) | - | - | ($8.41M) | - | - | $37.65M |
| Investing Cash Flow | - | - | - | ($27.13M) | - | - | ($31.74M) | - | - | ($62.77M) |
| Financing Cash Flow | - | - | - | ($334.0K) | - | - | ($5.63M) | - | - | ($37.08M) |
| CapEx | - | - | - | $28.41M | - | - | $32.64M | - | - | $62.05M |
| Free Cash Flow | - | - | - | ($43.87M) | - | - | ($41.05M) | - | - | ($24.40M) |
Ratios
| Metric | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | 38.9% | 39.3% | 38.2% | 38.1% | 38.1% | 37.8% | 36.8% | 38.7% | 38.9% |
| Operating margin | - | 2.0% | 2.9% | 1.1% | 0.3% | 0.2% | -1.1% | -82.5% | 1.6% | 1.8% |
| EBITDA margin | - | - | - | 4.4% | - | - | 2.1% | - | - | 4.9% |
| Net margin | - | 0.6% | 0.9% | -0.8% | -1.1% | -1.6% | -3.0% | -83.1% | -1.0% | -0.1% |
| Free cash flow margin | - | - | - | -2.9% | - | - | -2.7% | - | - | -1.6% |
| FCF / Net income | - | - | - | 3.76 | - | - | 0.88 | - | - | 12.90 |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | 36.9% | 36.4% | 37.1% | 37.8% | 37.9% | 38.9% | 37.5% | 37.2% | 37.1% |
| Effective tax rate | - | -205.5% | 5.1% | - | - | - | - | - | - | - |
| Return on assets | - | 0.2% | 0.3% | -0.2% | -0.3% | -0.5% | -0.9% | -22.9% | -0.2% | -0.0% |
| Return on equity | - | 0.8% | 1.2% | -1.1% | -1.5% | -2.2% | -4.0% | -104.0% | -0.6% | -0.1% |
| Return on invested capital | - | 1.1% | 1.5% | 0.5% | 0.1% | 0.1% | -0.5% | -35.2% | 0.5% | 0.5% |
| Liquidity | ||||||||||
| Current ratio | 0.90 | 0.91 | 0.89 | 0.85 | 0.84 | 0.84 | 0.85 | 0.90 | 0.95 | 0.98 |
| Quick ratio | 0.38 | 0.35 | 0.31 | 0.25 | 0.22 | 0.24 | 0.21 | 0.25 | 0.33 | 0.31 |
| Cash ratio | 0.23 | 0.22 | 0.18 | 0.12 | 0.10 | 0.11 | 0.08 | 0.13 | 0.16 | 0.15 |
| Leverage | ||||||||||
| Debt / Equity | 1.28 | 1.37 | 1.39 | 1.43 | 1.40 | 1.39 | 1.35 | 1.32 | 0.66 | 0.67 |
| Debt / Assets | 0.29 | 0.30 | 0.31 | 0.31 | 0.30 | 0.30 | 0.30 | 0.29 | 0.24 | 0.25 |
| Debt / EBITDA | - | - | - | 24.03 | - | - | 48.00 | - | - | 20.97 |
| Interest coverage | - | 0.9x | 1.3x | 0.5x | 0.1x | 0.1x | -0.5x | -33.7x | 0.6x | 0.7x |
| Equity multiplier | 4.44 | 4.50 | 4.52 | 4.62 | 4.64 | 4.66 | 4.52 | 4.55 | 2.76 | 2.74 |
| Liabilities / Assets | 0.77 | 0.78 | 0.78 | 0.78 | 0.78 | 0.79 | 0.78 | 0.78 | 0.64 | 0.63 |
| Efficiency | ||||||||||
| Asset turnover | - | 0.28 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.28 | 0.23 | 0.24 |
| Inventory turnover | - | 1.45 | 1.48 | 1.43 | 1.36 | 1.40 | 1.40 | 1.29 | 1.39 | 1.42 |
| Days sales outstanding | - | 11d | 8d | 9d | 10d | 11d | 10d | 12d | 16d | 11d |
| Days inventory outstanding | - | 252d | 246d | 255d | 269d | 260d | 262d | 282d | 263d | 256d |
| Days payable outstanding | - | 175d | 171d | 187d | 175d | 184d | 178d | 188d | 186d | 151d |
| Cash conversion cycle | - | 87d | 83d | 77d | 104d | 88d | 93d | 106d | 93d | 116d |
| Valuation | ||||||||||
| P / E | - | 106.0x | 58.4x | - | - | - | - | - | - | - |
| P / B | - | 0.8x | 0.7x | 0.8x | 1.1x | 0.0x | 0.0x | 0.7x | 0.9x | 1.1x |
| P / S | - | 0.6x | 0.6x | 0.6x | 0.8x | 0.0x | 0.0x | 0.6x | 1.4x | 1.7x |
| EV / EBITDA | - | - | - | 34.9x | - | - | 45.3x | - | - | 53.6x |
| Growth | ||||||||||
| Revenue growth (YoY) | - | -3.1% | -2.3% | -2.3% | 1.2% | -0.5% | -1.7% | -0.5% | 3.4% | 5.4% |
| Revenue CAGR (3y) | - | -0.8% | 0.2% | 0.4% | 6.3% | 2.0% | 2.6% | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | -1.2% | 0.8% | -1.5% | 4.7% | -2.1% | -4.3% | -8.0% | -0.2% | -0.5% |
| Operating income growth (YoY) | - | 634.1% | 1643.2% | - | - | -89.7% | - | - | -51.9% | -44.7% |
| Net income growth (YoY) | - | - | - | 74.9% | 98.7% | -70.0% | -2356.8% | - | - | - |
| EPS growth (YoY) | - | - | - | 76.5% | 98.7% | -80.0% | -1600.0% | - | - | - |
| EPS CAGR (3y) | - | -24.6% | 0.0% | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | -6.8% | - | - | -68.3% | - | - | -190.8% |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 5.1% | 3.1% | 0.7% | -4.7% | -5.9% | -53.1% | -51.6% | -48.8% | 6.0% | 4.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2026-01-31.
Product / service
$10.90B totalProduct$4.94B · 45.3%
Consumables$2.97B · 27.2%
Supplies And Companion Animals$1.97B · 18.1%
Services And Other$1.03B · 9.4%
Peer comparison
Same SIC group: Retail-Retail Stores, NEC
Comparing Petco Health & Wellness Company against the 5 most active filers in the same SIC group.